Lifshitz Law PLLC Announces Investigations of Kyndryl Holdings, Inc. (NYSE: KD), Corcept Therapeutics, Inc. (NASDAQ: CORT), NuScale Power Corporation (NYSE: SMR), and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE)
Lifshitz Law PLLC announced an investigation into Corcept Therapeutics regarding potential securities laws violations linked to its relacorilant drug. The firm alleges that Corcept overstated the strength of clinical trials and misled investors regarding regulatory prospects and confidence in FDA approval.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.